EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $443,000 | +295.5% | 35,737 | +96.6% | 0.00% | +300.0% |
| Q4 2018 | $112,000 | -87.2% | 18,176 | -71.9% | 0.00% | -83.3% |
| Q2 2018 | $877,000 | +296.8% | 64,760 | +458.3% | 0.01% | +500.0% |
| Q3 2017 | $221,000 | -78.2% | 11,600 | -82.7% | 0.00% | -83.3% |
| Q2 2017 | $1,013,000 | +579.9% | 67,054 | +445.2% | 0.01% | +500.0% |
| Q1 2016 | $149,000 | – | 12,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
| Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
| Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
| MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
| Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
| Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
| Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
| Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
| Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
| Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |